OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.
OncoPep has raised $11.0M in total funding. The most recent round was Series D. The last funding was announced in December 2021.
OncoPep's investors include Blood Cancer United, Inc., Crystal Bioscience, Kukje Pharma, Tera Science.
OncoPep is headquartered in North Andover, United States.
OncoPep is a developer of a multi-peptide therapeutic vaccine to prevent the progression of cancer.
OncoPep is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoPep — Funding & Investors." VCBacked, December 10, 2021, https://www.vcbacked.co/company/oncopep. Accessed August 15, 2026.
VCBacked. (2021). OncoPep — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/oncopep
{{cite web |title=OncoPep — Funding & Investors |url=https://www.vcbacked.co/company/oncopep |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated